One important indicator of national economic strength, in addition to real GDP, is its innovative capacity. Sustained investment in research and development (R&D) (and in human capital) is essential for the occurrence of innovation in an economy.
There are, however, significant variations in the extent of investment in R&D across economies.
In Chart 1, the ratios of R&D expenditure to GDP of the Group-of-Seven (G-7) countries (Canada, France, Germany, Italy, Japan, the United Kingdom and the United States), the four East Asian Newly Industrialized Economies (EANIEs) (Hong Kong, South Korea, Singapore and Taiwan), and China (Mainland) 2 are presented. From 1964 to 1990, R&D expenditure data are only available for West Germany. Thus, the R&D to GDP ratios and the quantities of real R&D capital stock of West Germany prior to 1991 are presented separately from those of the unified Germany, which are available since 1991.
The U.S. ratio started with a relatively low percentage, 1.36%, in 1953, but increased rapidly to 2.15% in 1957, partly as a reaction to the successful launch of the Sputnik satellite by the former Soviet Union. It has since held steady between 2.1% and 2.9% over the last half-a-century. The Chinese ratio started with a less than 0.1% in 1953, but increased rapidly to a peak of 2.57% in 1960, comparable to the U.S. ratio of the same year. Between 1963 and 1984, the Chinese ratio was higher than those of Canada, Italy and the four EANIEs. Then it plummeted below 1%, bottoming in 1996 at 0.57%. Since then it has been recovering steadily to reach 2.09% in 2014, once again surpassing the R&D expenditure to GDP ratios of Canada and Italy and that of the U.K., but still lagging significantly behind not only the developed economies of Germany, Japan and the U.S., but also the newly industrialized economies of South Korea and Taiwan. The Chinese ratio is targeted to reach 2.2% in 2015. The West German ratio was neck and neck with the U.S.
ratio between 1975 and 1990. However, since German reunification in 1990, the unified German ratio was below the U.S. ratio until 2011, when it finally managed to catch up 3 . The Japanese ratio was 1.47% in 1963 and rose steadily to overtake the U.S. ratio in 1989, and has remained significantly higher than it ever since. More recently, the South Korean ratio caught up with the U.S. ratio in 2005 and surpassed the Japanese ratio in 2010. South Korea led the world with an R&D expenditure to 2 In this study, data for China pertain to the Mainland of China only. 3 In 2011, the U.S. ratio was 2.84 compared to Germany's 2.80; in 2012, the ratios were respectively 2.89 and 2.88, almost identical.
GDP ratio of 4.15% in 2013. In 2011, the Taiwan ratio also surpassed the U.S. ratio.
Hong Kong, at less than 0.8%, has the lowest ratio of R&D expenditure to GDP among the economies in our study.
Chart 1: R&D Expenditure as a Percent of GDP:
G-7 Countries, 4 EANIES and China
The stock of real R&D capital, defined as the cumulative past real expenditure on R&D, less depreciation of ten percent per year, is a useful summary measure of the current potential capacity of innovation, as it typically takes years of cumulative efforts before investment in R&D pays off in terms of new discoveries and inventions.
The initial real R&D capital stocks at the beginning of the years for which data on R&D expenditure are first available are not known and have to be separately estimated for each economy. (The estimation procedure is described in Appendix I.)
Given estimates of the initial real R&D capital stocks, and the time series of real R&D expenditures, time-series of the real R&D capital stocks can be estimated for all the economies in our study. In Chart 2, the real R&D capital stocks (in 2012 U.S. In Chart 3, we compare the R&D capital stocks per capita at the beginning of each year across the same set of economies. By this measure, the lead of the U.S.
over other economies was consistent and large until it was overtaken by Japan in 1996.
They were followed by Germany. (West Germany had a real R&D capital stock per capita comparable to that of the U.S. in the late 1980s.) The three
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As noted above, for small economies, the numbers of their U.S. patent applications may far exceed the numbers of their domestic applications.
Again, in order to adjust for the effect of the size of the economy, in Chart 7, the number of U. S. patent applications submitted by the citizens of each country or region divided by its total domestic population each year is presented. The U.S. was the leader in the number of U.S. patent applications per capita until it was overtaken overtook Japan (0.669) in 2013 to become the third highest in our set of economies.
China has remained in the last place because of its large population.
Chart 7: U.S. Patent Applications Filed Annually per Thousand Persons

G-7 Countries, 4 EANIEs and China
An interesting indicator is the U.S. patent application rate of each economy, defined as the ratio of the number of U.S. patent applications to the number of domestic patent applications. Given that patent applications and maintenance are costly, especially in a foreign jurisdiction, the U.S. patent application rate may provide information on the self-perceived quality of the discoveries and inventions that underlie the patent applications. However, for economies in which the U.S.
patent application rate exceeds 100 percent, it is not going to be a good indicator of the self-perceived quality of the U.S. patent applications from these economies. The In Chart 9, we present the U.S. patent application rates of those economies with U.S. application rates less than or equal to 100 percent. For the U.S., its U.S. application rate is by definition 100 percent. The U.K. has the highest U.S. patent application rates among this group of economies, which excludes those economies with U.S. patent application rates exceeding 100 percent, of 65.5% in 2013. It was followed by France, with an application rate of 46.7% in 2013. The U.S. patent application rates of the other economies have on the whole been rising since the late 1990s, some more rapidly than the others, with the exception of China. China has by far the lowest U.S. patent application rates, with a rate of slightly over 2% in 2013. 7 The data on domestic applications of Italy, collected from the World Intellectual Property Organization (WIPO), appear to have some problems. The data have been adjusted. The adjusted data have been used to calculate the U.S. application rates. 8 One can also choose a two year lag for the number of domestic applications. It all depends on the time required for processing of patent applications by the relevant domestic patent authorities. 9 The success rate may occasionally exceed 100%, as, for example in the case of France, because of variations in the time elapsed between the submission of patent applications and the award of patent grants. 10 The U.K. had the lowest domestic patent success rate in 2013 but the Chinese domestic patent success rate for 2014 appeared likely to be lower than that of the U.K., data for which is not yet available. In Chart 12, the number of patents granted in the United States by the U.S. 1952  1954  1956  1958  1960  1962  1964  1966  1968  1970  1972  1974  1976  1978  1980  1982  1984  1986  1988  1990  1992  1994  1996  1998  2000  2002  2004  2006  2008  2010  2012 It is also interesting to examine the relationship between the domestic patent application success rate and the U.S. patent application success rate of each economy.
This can provide some indirect evidence on the quality of the domestic patents granted compared to the U.S. patents granted and its evolution over time. In Chart 16, the U.S. patent application success rate is plotted against the domestic patent application success rate of each economy each year, where we have omitted the data of economies with an U.S. patent application rate of over 100 percent in any one year.
While there appears to be a generally positive correlation between the U.S. patent success rate and the domestic patent success rate for some economies, the correlation is not strong. An interesting question is whether the U.S. patent application rate of an economy is influenced by its past U.S. patent application success rates. In Chart 17, a scatter diagram between the U.S. patent application rate of an economy and its lagged U.S. patent success rate is presented. Again, we have omitted the data of economies with an U.S. patent application rate of over 100 percent in any one year.
However, for most of the economies, there is no obvious discernible pattern; except The real R&D capital stock can be shown to have a direct causal relationship to the number of patents granted. In Chart 18, the number of domestic patents granted to the citizens of a country or region is plotted against its real R&D capital stock at the beginning of that year. In Chart 19 12 , the number of U.S. patents granted to the citizens of a country or region is plotted against its real R&D capital stock at the beginning of that year. Both charts show clearly that the higher the level of the real R&D capital stock of an economy, the higher is the number of domestic and U.S.
patents granted to it. On an economy-by-economy basis, the positive correlation may not be so obvious (see, for example, France, West Germany and the U.K. as well as the early phases of South Korea and Singapore and even the U.S. 
The positive correlation between the number of patents granted and the real R&D capital stock is stronger for U.S. patents granted than domestic patents granted.
We believe this may possibly be due to self-selection on the part of the foreign applicants who would choose to submit applications only for patents perceived to be of higher quality and more uniform standards on patent grants on the part of the USPTO.
We may also note that there exist significant systematic differences in the efficiency in the generation of domestic and U.S. patent grants across economies, in the sense that for a given level of real R&D capital stock, the number of domestic or U.S. patents granted can be quite different across economies. For domestic patent grants, South Korea, China and Japan appear to have the highest efficiencies, and Italy, Canada, the U.K., Germany and the U.S. appear to have the lowest efficiencies. For U.S. patent grants, China appears to have the lowest efficiencies and the U.S. and Taiwan seem to have the highest efficiencies. We believe that the relative efficiencies in the generation of U.S. patent grants are probably more reliable because all economies face the same uniform standards of the USPTO as opposed to the possibly differing standards maintained by the respective domestic patent offices. under study with a basic research ratio of around 25%. The United States ratio has averaged almost 20% over the past ten years, whereas Japan and the U.K. had ratios in the low teens. The Taiwan ratio was around 10%. China had the lowest ratio at around 5%. C. The real R&D expenditures in national currencies are converted to U.S.
Dollars, using the 2012 year-end exchange rates collected from the IFS database and from national statistical sources.
The Estimation of the Initial Real R&D Capital Stocks
In order to construct time-series of real R&D capital stocks from time-series data on real R&D expenditure of each economy, we need first of all to estimate the initial real R&D capital stocks 0 i K 's for each economy. Once an estimate of the initial real R&D capital stock is available, a time-series of real R&D capital stock can be readily constructed using the perpetual inventory method and assuming a rate of depreciation of R&D capital of 10 percent per annum.
To estimate the initial capital stock, we assume that the annual number of domestic patent applications of an economy is a function of its augmented real R&D capital stock:
where iDt YA is the number of domestic patent applications of economy i in year t,
K is the quantity of efficiency-equivalent (or augmented) real R&D capital stock of economy i in year t, and t is the time trend, valued from 1 to t. It is further assumed that * it K is related to it K , the quantity of measured real R&D capital stock, by an economy-specific and time-varying multiplicative augmentation factor:
Moreover, it is assumed that the function F(.) in equation (A1) (A6)
K it , the stock of real R&D capital, may be defined as 
The Estimation of the Time-Series of Real R&D Capital Stocks
Given the time-series of real R&D expenditures and the initial real capital stocks estimated above, the real R&D capital stocks for each economy can be estimated using equation (A7):
( 1) where K i0 is the initial real R&D capital stock of economy i and I i(t-j) is the real R&D expenditure of economy i in year t-j. 
Estimated Real R&D Capital Stocks of Selected Economies
